ArticleThe Journal of biological chemistry2013

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD).

Ronit Shaltiel-Karyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.